Randomized Controlled Trial of Desonlde Hydrogel 0.05% versus Desonide Ointment 0.05% in the Treatment of Mild-to-moderate Atopic Dermatitis

Objective: Desonide hydrogel 0.05%, an effective treatment for mild-to-moderate atopic dermatitis, is United States Food and Drug Administration approved as a treatment for patients as young as three months of age. Previous studies have also demonstrated that this hydrogel formulation of desonide 0....

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Trookman, Nathan S., Rizer, Ronald L.
פורמט: Artigo
שפה:Inglês
יצא לאור: Matrix Medical Communications 2011
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3225140/
https://ncbi.nlm.nih.gov/pubmed/22125657
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים